Centrum Medyczne ENEL-MED S.A.

WSE:ENE Stok Raporu

Piyasa değeri: zł565.6m

Centrum Medyczne ENEL-MED Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Centrum Medyczne ENEL-MED.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare kazanç büyümesi21.5%
Gelir büyüme oranın/a
Gelecekteki özkaynak getirisin/a
Analist kapsamı

None

Son güncellemen/a

Gelecekteki son büyüme güncellemeleri

Recent updates

Centrum Medyczne ENEL-MED's (WSE:ENE) Solid Earnings Are Supported By Other Strong Factors

May 30
Centrum Medyczne ENEL-MED's (WSE:ENE) Solid Earnings Are Supported By Other Strong Factors

Calculating The Fair Value Of Centrum Medyczne ENEL-MED S.A. (WSE:ENE)

Apr 21
Calculating The Fair Value Of Centrum Medyczne ENEL-MED S.A. (WSE:ENE)

Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital Not Reflecting Well On The Business

May 12
Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital Not Reflecting Well On The Business

Is Centrum Medyczne ENEL-MED (WSE:ENE) A Risky Investment?

Jun 09
Is Centrum Medyczne ENEL-MED (WSE:ENE) A Risky Investment?

Is There More Growth In Store For Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital?

Feb 22
Is There More Growth In Store For Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital?

We Think Centrum Medyczne ENEL-MED (WSE:ENE) Can Stay On Top Of Its Debt

Feb 01
We Think Centrum Medyczne ENEL-MED (WSE:ENE) Can Stay On Top Of Its Debt

We Think Centrum Medyczne ENEL-MED's (WSE:ENE) Statutory Profit Might Understate Its Earnings Potential

Jan 11
We Think Centrum Medyczne ENEL-MED's (WSE:ENE) Statutory Profit Might Understate Its Earnings Potential

Can Mixed Fundamentals Have A Negative Impact on Centrum Medyczne ENEL-MED S.A. (WSE:ENE) Current Share Price Momentum?

Dec 21
Can Mixed Fundamentals Have A Negative Impact on Centrum Medyczne ENEL-MED S.A. (WSE:ENE) Current Share Price Momentum?

Does Centrum Medyczne ENEL-MED's (WSE:ENE) Share Price Gain of 92% Match Its Business Performance?

Nov 30
Does Centrum Medyczne ENEL-MED's (WSE:ENE) Share Price Gain of 92% Match Its Business Performance?

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Centrum Medyczne ENEL-MED yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

WSE:ENE - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (PLN Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
6/30/202468074588N/A
3/31/2024654165095N/A
12/31/202361984881N/A
9/30/202358972766N/A
6/30/202354272064N/A
3/31/2023522-23353N/A
12/31/2022495-24-640N/A
9/30/2022476-30-445N/A
6/30/2022476-27-346N/A
3/31/2022450-71759N/A
12/31/2021441-12967N/A
9/30/2021427-33056N/A
6/30/2021419-14158N/A
3/31/202139846577N/A
12/31/2020400-36374N/A
9/30/202040747688N/A
6/30/2020410-17790N/A
3/31/2020424-84367N/A
12/31/2019418-24575N/A
9/30/2019406-73061N/A
6/30/2019393-1740N/A
3/31/2019382-3630N/A
12/31/2018372-1-515N/A
9/30/2018360-7-711N/A
6/30/2018350-9-220N/A
3/31/2018338-5N/A27N/A
12/31/2017324-3N/A24N/A
9/30/20173092N/A30N/A
6/30/20172964N/A26N/A
3/31/20172853N/A20N/A
12/31/20162742N/A17N/A
9/30/20162651N/A18N/A
6/30/2016254-1N/A12N/A
3/31/2016244-2N/A11N/A
12/31/20152351N/A16N/A
9/30/20152262N/A8N/A
6/30/20152194N/A11N/A
3/31/201521642N/A13N/A
12/31/201421442N/A12N/A
9/30/201421643N/A16N/A
6/30/201421842N/A21N/A
3/31/20142124N/A18N/A
12/31/20132072N/A18N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if ENE's forecast earnings growth is above the savings rate (3.9%).

Kazançlar ve Piyasa: Insufficient data to determine if ENE's earnings are forecast to grow faster than the Polish market

Yüksek Büyüme Kazançları: Insufficient data to determine if ENE's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if ENE's revenue is forecast to grow faster than the Polish market.

Yüksek Büyüme Geliri: Insufficient data to determine if ENE's revenue is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if ENE's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin